INVITROGEN CORPORATION for INVITROGEN CORPORATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; CREDIT MARKET STABILITY
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Copyright/Patent/Trademark CPT
S3600: PATENT REFORM ACT OF 2008; DAMAGES, RESEARCH USE EXCEPTION AND PATENT AND TRADEMARK OFFICE REFORM S1145: PATENT REFORM ACT OF 2007; DAMAGES, RESEARCH USE EXCEPTION AND PATENT AND TRADEMARK OFFICE REFORM
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Health Issues HCR
HR6498/S976: GENOMICS AND PERSONALIZED MEDICINE ACT; ALL ASPECTS OF BILL S3408: COMPARATIVE EFFECTIVENESS RESEARCH ACT OF 2008; ALL ASPECTS OF BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Budget/Appropriations BUD
S3230: DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND RELATED AGENCIES APPROPRIATIONS ACT, 2009; NATIONAL INSTITUTES OF HEALTH & BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY FUNDING
| Lobbyist | Covered position, as disclosed |
|---|---|
| JANET LYNCH LAMBERT | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.